Enhanced release of synaptic glutamate underlies the potentiation of oxygen-glucose deprivation-induced neuronal injury after induction of NOS-2

Exp Neurol. 2004 Nov;190(1):91-101. doi: 10.1016/j.expneurol.2004.06.018.

Abstract

Reactive nitrogen oxide species (RNOS) may contribute to the progression/enhancement of ischemic injury by augmentation of glutamate release, reduction of glutamate uptake, or a combination of both. Consistent with this, induction of nitric oxide synthase (NOS-2) in murine neocortical cell cultures potentiated neuronal cell death caused by combined oxygen-glucose deprivation in association with a net increase in extracellular glutamate accumulation. However, uptake of glutamate via high affinity, sodium-dependent glutamate transporters was unimpaired by induction of NOS-2 under either aerobic or anaerobic conditions. Further, blocking possible routes of extra-synaptic glutamate release with NPPB [5-nitro-2-(3-phenylpropylamino)-benzoic acid], a volume-sensitive organic anion channel blocker, or TBOA (d,l-threo-beta-benzyloxyaspartate), an inhibitor of glutamate transport, exacerbated rather than ameliorated injury. Finally, treatment with riluzole or tetanus toxin attenuated the enhancement in both glutamate accumulation and oxygen-glucose deprivation-induced neuronal injury supporting the idea that increased synaptic release of glutamate underlies, at least in part, the potentiation of neuronal injury by RNOS after NOS-2 induction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aspartic Acid / pharmacology
  • Cell Death / drug effects
  • Cell Hypoxia
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Enzyme Induction
  • Extracellular Space / metabolism
  • Glucose / deficiency
  • Glucose / metabolism*
  • Glutamic Acid / metabolism*
  • Hypoxia-Ischemia, Brain / enzymology
  • Hypoxia-Ischemia, Brain / metabolism*
  • Mice
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neuroprotective Agents / pharmacology
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type II
  • Nitrobenzoates / pharmacology
  • Riluzole / pharmacology
  • Synapses / metabolism*
  • Tetanus Toxin / pharmacology

Substances

  • Neuroprotective Agents
  • Nitrobenzoates
  • Tetanus Toxin
  • benzyloxyaspartate
  • Aspartic Acid
  • 5-nitro-2-(3-phenylpropylamino)benzoic acid
  • Glutamic Acid
  • Riluzole
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Glucose